Close Menu
  • Home
  • Vaccines
  • Politics
  • Health
  • Tech
  • Sports
  • Research
  • Fitness
  • Careers
What's Hot

Health Canada approves Novartis’ KISQALI® for HR+/HER2- early breast cancer patients at high risk of recurrence

Sheriff, county lawyer seeking mental health funds at Minnesota State Capitol

Chronic absences have not disappeared. Research shows that poor children are most hurt.

Facebook X (Twitter) Instagram
subjectional.com
Subscribe
  • Home
  • Vaccines
  • Politics
  • Health
  • Tech
  • Sports
  • Research
  • Fitness
  • Careers
subjectional.com
Home » Reducing RSV risk in older adults | News
Vaccines

Reducing RSV risk in older adults | News

Paul E.By Paul E.October 10, 2024No Comments2 Mins Read
Share Facebook Twitter Pinterest Copy Link Telegram LinkedIn Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email


October 10, 2024 – Respiratory syncytial virus (RSV) is a common virus that typically causes cold-like symptoms, but can cause severe illness in older adults, especially those over 75. Therefore, RSV vaccination is important for prevention. Kizmekia Corbett-Helaire, assistant professor of immunology and infectious diseases at Harvard’s T.H. Chan School of Public Health, points to the possibility of an infectious disease.

On the Oct. 3 WebMD podcast, Corbett-Helaire said that while RSV is commonly known to infect young children, it is more common in older adults, especially groups with chronic conditions such as diabetes and heart disease. He explained that there is an increased risk of severe illness and hospitalization.

“The most important thing to remember when it comes to preventing disease, especially severe disease, is that vaccines are overall the most valuable tool for prevention,” said Dr. Corbett-Helaire. The novel coronavirus disease (COVID-19) pandemic.

He said that during vaccine development, a vaccine is generally considered good if it is 50-60% effective at preventing serious infections. Previous studies have shown that the RSV vaccine is 80-90% effective. Such a level of protection is “remarkable and means the vaccine is really good,” Corbett-Helaire said, noting that one dose appears to provide high protection for about two years. did.

Listen to the WebMD podcast or read the transcript: Understanding RSV in Older Adults: Risks, Symptoms, and Prevention

– Jay Lau

Photo: iStock/Zinkevich



Source link

Follow on Google News Follow on Flipboard
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Copy Link
Previous ArticleLatest COVID-19 vaccine now available in Arkansas
Next Article Respiratory disease season is here, get vaccinated now
Paul E.
  • Website

Related Posts

Kentucky leaders emphasize whooping cough vaccination

October 31, 2024

Safety, efficacy and immunogenicity of aerosolized Ad5-nCoV COVID-19 vaccine in a non-inferiority randomized controlled trial

October 31, 2024

Trust is important, but increasing vaccination rates also requires three things

October 31, 2024
Leave A Reply Cancel Reply

Latest Posts

Health Canada approves Novartis’ KISQALI® for HR+/HER2- early breast cancer patients at high risk of recurrence

Sheriff, county lawyer seeking mental health funds at Minnesota State Capitol

Chronic absences have not disappeared. Research shows that poor children are most hurt.

Transport Secretary reveals overhaul of aging pneumatic transport systems

Latest Posts

Subscribe to News

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

Welcome to Subjectional!

At Subjectional, we believe that informed opinions are the foundation of a vibrant society. Our mission is to provide insightful, engaging, and balanced information across a diverse range of topics that matter to you. Whether you’re interested in the latest developments in health, navigating the complexities of politics, staying updated on sports, exploring technological advancements, or advancing your career, we’ve got you covered.

Facebook X (Twitter) Instagram Pinterest YouTube

Subscribe to Updates

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

Facebook X (Twitter) Instagram Pinterest
  • Home
  • About Us
  • Advertise with Us
  • Contact us
  • DMCA
  • Privacy Policy
  • Terms & Conditions
© 2025 subjectional. Designed by subjectional.

Type above and press Enter to search. Press Esc to cancel.